Xin Shen , Yang Li , Xinru Kang , Chenhui Zhu , Zhiguang Duan , Rongzhan Fu
{"title":"An injectable hyaluronic acid-based hydrogel for the treatment of breast cancer","authors":"Xin Shen , Yang Li , Xinru Kang , Chenhui Zhu , Zhiguang Duan , Rongzhan Fu","doi":"10.1016/j.colsurfb.2025.115100","DOIUrl":null,"url":null,"abstract":"<div><div>In this study, we develop a hyaluronic-tannic acid (HA-TA) hydrogel loaded with Cu nanoparticles attach to MXene (MXene@Cu) to explore its potential as a targeted breast cancer treatment. The MXene@Cu nanosheets exhibit activity in depleting glutathione (GSH) and inducing reactive oxygen species (ROS) through the Fenton-like reaction. They can down-regulate the activity of glutathione peroxidase 4 (GPX4), leading to the accumulation of lipid peroxides (LPO) and inducing ferroptosis in tumor cells. GSH depletion enhances both ferroptosis and apoptosis efficacy. Additionally, under photothermal therapy (PTT), accelerated GSH consumption and the Fenton-like reaction further amplify ferroptosis and apoptosis. Injectable hyaluronic acid-based hydrogel adheres to tumor tissue, enabling local treatment and precise PTT, thereby improving treatment efficiency. In summary, the HA-TA/MXene@Cu hydrogel synergistically enhance oxidative stress and consume GSH, triggering ferroptosis and amplifying photothermal-mediated apoptosis, leading to potent inhibition of breast cancer growth. This innovative therapeutic modality presents a promising approach for precise and effective local breast cancer treatment.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"257 ","pages":"Article 115100"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0927776525006071","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
In this study, we develop a hyaluronic-tannic acid (HA-TA) hydrogel loaded with Cu nanoparticles attach to MXene (MXene@Cu) to explore its potential as a targeted breast cancer treatment. The MXene@Cu nanosheets exhibit activity in depleting glutathione (GSH) and inducing reactive oxygen species (ROS) through the Fenton-like reaction. They can down-regulate the activity of glutathione peroxidase 4 (GPX4), leading to the accumulation of lipid peroxides (LPO) and inducing ferroptosis in tumor cells. GSH depletion enhances both ferroptosis and apoptosis efficacy. Additionally, under photothermal therapy (PTT), accelerated GSH consumption and the Fenton-like reaction further amplify ferroptosis and apoptosis. Injectable hyaluronic acid-based hydrogel adheres to tumor tissue, enabling local treatment and precise PTT, thereby improving treatment efficiency. In summary, the HA-TA/MXene@Cu hydrogel synergistically enhance oxidative stress and consume GSH, triggering ferroptosis and amplifying photothermal-mediated apoptosis, leading to potent inhibition of breast cancer growth. This innovative therapeutic modality presents a promising approach for precise and effective local breast cancer treatment.
期刊介绍:
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.
The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.